Quarterly report pursuant to Section 13 or 15(d)

Schedule of segment information (Details)

v3.23.1
Schedule of segment information (Details) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Net sales $ 2,175,135 $ 1,848,898  
Operating income (loss) 72,614 31,376  
Interest income 6,660 14,353  
Interest expense 18,959 18,207  
Property Additions 27,902  
Fixed asset depreciation and amortization 14,446 15,890  
Total assets 5,232,093 4,836,918 $ 4,993,892
Cannabis and Medical Marijuana Segment [Member]      
Segment Reporting Information [Line Items]      
Net sales 9,017  
Operating income (loss) (706) 5,491  
Interest income  
Interest expense  
Property Additions  
Fixed asset depreciation and amortization  
Total assets 812 879,789  
Facility Operations Related [Member]      
Segment Reporting Information [Line Items]      
Net sales 2,175,135 1,839,881  
Operating income (loss) 244,054 187,150  
Interest income  
Interest expense 16,163 10,386  
Property Additions 27,902  
Fixed asset depreciation and amortization 14,208 15,368  
Total assets 3,623,663 2,411,343  
Corporate and Eliminations [Member]      
Segment Reporting Information [Line Items]      
Net sales  
Operating income (loss) (170,734) (161,265)  
Interest income 6,660 14,353  
Interest expense 2,796 7,821  
Property Additions  
Fixed asset depreciation and amortization 238 522  
Total assets $ 1,607,618 $ 1,545,786